• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE Back to Search Results
Model Number TSH
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/14/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with the elecsys tsh assay, elecsys ft3 iii, and the elecsys ft4 iii assay on a cobas 8000 e 801 module.No incorrect results were reported outside of the laboratory.This medwatch will apply to the tsh assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay and refer to the medwatch with patient identifier (b)(6) for information related to the ft4 assay.The sample resulted with a tsh value of 0.04 uiu/ml when tested on the e 801 analyzer.The sample was repeated on an architect analyzer, resulting with a tsh value of 0.027 uiu/ml.The sample was treated with polyethylene glycol (peg) and repeated for tsh on the e 801 analyzer, resulting with a 100 % recovery.The sample resulted with a ft3 value of 7.47 pg/ml when tested on the e 801 analyzer.The sample was repeated on an architect analyzer, resulting with a ft3 value of 4.63 pg/ml.The sample was treated with polyethylene glycol (peg) and repeated for ft3 on the e 801 analyzer, resulting with a 72.8 % recovery.The sample resulted with a ft4 value of 2.98 ng/dl when tested on the e 801 analyzer.The sample was repeated on an architect analyzer, resulting with a ft4 value of 1.38 ng/dl.The sample was treated with polyethylene glycol (peg) and repeated for ft4 on the e 801 analyzer, resulting with a 114.8 % recovery.The e801 analyzer serial number is (b)(4).
 
Manufacturer Narrative
One sample was sent for additional investigation for possible interfering factors.Based on the available data, an interfering factor could be excluded and a general reagent issue could be excluded.Assays from different vendors can generate different values.This relates to the overall setups of the assays, the antibodies used and, differences in reference materials/methods and the standardization methodology used.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TSH ASSAY
Type of Device
RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9340872
MDR Text Key219608848
Report Number1823260-2019-04102
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
PMA/PMN Number
K961491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTSH
Device Catalogue Number07028091190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
THYRADIN
-
-